PSMA-PET for the assessment of metastatic hormone-sensitive prostate cancer volume of disease. Barbato F, Fendler WP, Rauscher I, Herrmann K, et al. J Nucl Med 2021 May 14. pii: jnumed.121.262120. doi: 10.2967/jnumed.121.262120.

Read + Share

Amedeo Smart

Independent Medical Education

Barbato F, Fendler WP, Rauscher I, Herrmann K, et al. PSMA-PET for the assessment of metastatic hormone-sensitive prostate cancer volume of disease. J Nucl Med 2021 May 14. pii: jnumed.121.262120. doi: 10.2967/jnumed.121.262120.
PMID: 33990403